Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Divergent trajectories of antiviral memory after SARS-CoV-2 infection.

Journal article

Tomic A. et al, (2022), Nature communications, 13

Infection of liver hepatocytes with SARS-CoV-2.

Journal article

Barnes E., (2022), Nature metabolism, 4, 301 - 302

A haemagglutination test for rapid detection of antibodies to SARS-CoV-2

Journal article

Townsend A. et al, (2021), Nature Communications, 12

Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy

Journal article

Smith DA. et al, (2021), Journal of Viral Hepatitis, 28, 1256 - 1264

Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations

Journal article

Mokaya J. et al, (2021), Journal of Viral Hepatitis, 28, 1110 - 1120

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

Journal article

Liu C. et al, (2021), Cell, 184, 4220 - 4236.e13

Therapeutic vaccination for treatment of chronic hepatitis B.

Journal article

Cargill T. and Barnes E., (2021), Clinical and experimental immunology, 205, 106 - 118

Antibody evasion by the P.1 strain of SARS-CoV-2

Journal article

Dejnirattisai W. et al, (2021), Cell, 184, 2939 - 2954.e9

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

Journal article

Zhou D. et al, (2021), Cell, 184, 2348 - 2361.e6

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

Journal article

Supasa P. et al, (2021), Cell, 184, 2201 - 2211.e7

COVID-19 and liver disease: mechanistic and clinical perspectives.

Journal article

Marjot T. et al, (2021), Nat Rev Gastroenterol Hepatol

Load More